EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+59.14%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$605M
AUM Growth
+$605M
(+59%)
Cap. Flow
+$75.6M
Cap. Flow
% of AUM
12.49%
Top 10 Holdings %
Top 10 Hldgs %
55.57%
Holding
81
New
22
Increased
20
Reduced
20
Closed
14
Top Buys
Top Sells
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$31M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$27.2M |
| 3 |
Danaher
DHR
|
$22.3M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$15.6M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$12.8M |
Sector Composition
| 1 | Healthcare | 96.24% |
| 2 | Communication Services | 1.96% |
| 3 | Financials | 0% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Health Care Select Sector SPDR Fund
XLV
$33.9B
| – | – | 0 | – | – |
|
|
AGRX
77
DELISTED
Agile Therapeutics, Inc
AGRX
| – | – | -711,756 | Closed | -$1.32M |
|
|
XLRN
78
DELISTED
Acceleron Pharma Inc.
XLRN
| – | – | -42,305 | Closed | -$3.8M |
|
|
KDMN
79
DELISTED
Kadmon Holdings, Inc.
KDMN
| – | – | -975,350 | Closed | -$4.09M |
|
|
GNMK
80
DELISTED
GenMark Diagnostics, Inc
GNMK
| – | – | -524,257 | Closed | -$2.16M |
|
|
PFNX
81
DELISTED
Pfenex Inc.
PFNX
| – | – | -46,293 | Closed | -$408K |
|